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INTRODUCTION
The immature neonatal and early-infant brain differs from
the mature adult brain in its susceptibility to seizures, seizure
characteristics, and responses to antiepileptic drugs (1, 2).
While the immature brain is resistant to acute seizure-ind-
uced cell loss, there are functional abnormalities following
seizures with impairment of visual-spatial memory and redu-
ced seizure threshold. Furthermore, seizures in early-life are
associated with an increased likelihood of chronic epilepsy and
may themselves contribute to epileptogenesis through adverse
effects on brain development (3-5). However, the effects of
repeated seizures on the developing brain have long been de-
bated.
Numerous models have been used in the past to determine
how early-life seizures exert their effects on the developing
brain according to different questions. Nevertheless, the basic
questions are often the same as follows: Do seizures cause lo-
ng-term damage? Do seizures predispose to chronic epilepsy
(epileptogenesis) which is long-term spontaneous repetitive
seizures? Are these results developmentally regulated? Are the
underlying mechanisms of epileptogenesis and brain damage
related?
Tetanus toxin, a large protein (MW 150 kDa) produced by
Clostridium tetani, is a well-known neurotoxin and potent
convulsant and has been used by numerous laboratories to
produce seizures in adult animals of several species (6-8). Lee
et al. (9) introduced the tetanus-induced seizures models that
permit study of the acute and chronic effects of multiple early-
life seizures on the developing brain. 
Meanwhile, nitric oxide (NO) is produced by nitric oxide
synthase (NOS) from L-arginine. Three isofroms of NOS have
been identified and are expressed in different tissues. In the
brain, a calcium-calmodulin-dependent and constitutive NOS
is localized to certain neuronal populations. This so called neu-
ronal isoform of NOS (nNOS) is activated by glutamate via
NMDA receptors. NO is thought to be involved in various
functions including, vasodilatation, immune function, neu-
rocytotoxicity, long-term potentiation and long-term depres-
sion, memory processes, synaptic plasticity, and the regula-
tion of excitability and firing (10). Also, NO mediates the
formation of synaptic connections and regeneration of neu-
rons in the process of brain development (11). The expres-
sion of nNOS mRNA is widely distributed in the brain, such
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Increased Seizure Susceptibility and Up-regulation of nNOS Expression
in Hippocampus Following Recurrent Early-life Seizures in Rats 
This study aimed to determine the long-term change of seizure susceptibility and the
role of nNOS on brain development following recurrent early-life seizures in rats. Vi-
deo-EEG recordings were conducted between postnatal days 50 and 60. Alterations
in seizure susceptibility were assayed on day 22 or 50 using the flurothyl method.
Changes in nNOS expression were determined by quantitative immunoblotting on
day 50. On average, rats had 8.4±2.7 seizures during 10 daily 1 hr behavioral mon-
itoring sessions. As adults (days 50-60), all rats displayed interictal spikes in the hip-
pocampus and/or overlying cortex. Brief electrographic seizures were recorded in
only one of five animals. Rats appeared to progress from a period of marked seizure
susceptibility (day 22) to one of lessened seizure susceptibility (day 50). Up-regu-
lation of nNOS expression following early-life recurrent seizures was observed on
day 50. In conclusion, these data suggested that recurrent early-life seizures had
the long-term effects on seizure susceptibility late in life and up-regulatory nNOS
expression on the hippocampus during brain development, and nNOS appeared
to contribute to the persistent changes in seizure susceptibility, and epileptogenesis.
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amygdala, cerebral cortex, and cerebellum (12). 
This study aimed to determine the effects of repeated seiz-
ures on the developing brain by evaluating the long-term cha-
nges in seizure susceptibility and nNOS expression late in life
following recurrent seizures in early-life induced by a unilat-
eral intrahippocampal injection of tetanus toxin. 
MATERIALS AND METHODS
Tetanus toxin injection
Wistar rat pups (Harlan Sprague Dawley, Indianapolis, IN,
USA), 10 days of age, were anesthetized with an intraperi-
toneal injection of ketamine and xylazine (33 and 1.5 mg/kg,
respectively). Tetanus toxin (TNTX, 2.5 or 5 ng) was disso-
lved in sterile saline (20 or 40 nL) and stereotaxically inject-
ed into the right dorsal hippocampus. The tetanus toxin used
in this study was a gift of the Massachusetts State Biological
Labs (North Worcester, MA, USA). The potency of the toxin
was assayed by hindlimb paralysis after injection into the gas-
trocnemius muscle. The minimal dose (MD100) that produced
paralysis in all mice in a group (n=5) was 0.25 ng (9). The
surgical procedures and use of tetanus toxin were approved
by an Animal Protocol Review Committee, the Infectious
Agent and Hazardous Chemical Subcommittee, and the Ani-
mal Biosafety Subcommittee of the Baylor College of Medi-
cine (Department of Pediatrics, Division of Neuroscience,
Cain laboratory, March 2002-April 2003, IACUC; AN-
652). All procedures were in keeping with guidelines estab-
lished by the National Institutes of Health (Bethesda, MD,
USA). To inject tetanus toxin, the pups were placed in an
infant rat stereotaxic head holder, a midline incision was
made, and a small hole was drilled in the skull. The stereo-
taxic coordinates for the injection were as follows: anteropos-
terior, -2.2 mm; mediolateral, 3.0 mm from the bregma;
and dorsoventral, -2.95 mm from the dural surface. The
toxin was slowly injected at 4 nL/min. After injection, the
needle was left in place for 10 min to reduce reflux up the
needle track. During injections, the body temperature of the
rat pups was maintained by a warmed (electrically regulat-
ed) metal plate. Littermates, stereotaxically injected with
sterile saline, or untreated rats served as controls (Table 1). 
Behavioral monitoring of seizures in infant rats 
The frequency of behavioral seizures was monitored 1 hr
each day for 10 consecutive days after tetanus toxin injections.
The types and duration of seizures were noted. Wild running
seizures were most easily identified. Rats that had a total of
2 or more wild running seizures during the 10 monitoring
sessions were selected for performing western blots, seizure
susceptibility tests, and video-EEG monitoring. Other than
seizures, no other behavioral signs of neurological abnormal-
ities were observed in the tetanus toxin-treated rats.
EEG electrode implantation
At 50-60 days-of-age, EEG electrodes were implanted in 5
toxin-treated animals, 2 saline-injected animals, and 3 untr-
eated controls rats. Chlorided silver wires (exposed tips of 0.005
inches in diameter, Teflon coated silver wires, A-M Systems,
Inc., Carlsborg, WA, USA) were stereotaxically implanted
bilaterally in each hippocampus and over each somatosenso-
ry cortex (surface electrodes). A reference electrode was
placed over the right occipital cortex. These electrodes were
held in place with dental acrylic. A ground electrode was
placed in the right occipital muscle group. Dental cement
was used to secure the electrode wires in place and to form a
protective cap around a plug to which the electrodes were
connected.  
Video EEG monitoring
During the week following EEG electrode implantation,
a 20 channel Nihon Kohden EEG machine with an attached
video camera was used to monitor each animal twice for at
least 2 hr during each recording session. Recordings were
made at a paper speed of 30 mm/sec and a sensitivity of 30-
75 μ V/mm. A referential montage was used in which the left
and right cortical and hippocampal electrodes were referred
to the medial occipital cortex.
Western blotting
On postnatal day 50, rats were anesthetized with isoflu-
rane vapors and the brains were quickly removed and sub-
merged in ice-cold ACSF (sucrose 110 mM, NaCl 60 mM,
KCl 3 mM, NaH2PO4 1.25 mM, NaHCO3 28 mM, CaCl2
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TNTX, tetanus toxin treated; SC, saline injected; NC, normal control; PND, postnatal day.
Behavioral monitoring
of seizures (n)
Animal group
Early seizure susceptibility, 
PND 22 (n)
Western blot,
PND 45 (n) 
Late seizure susceptibility, 
PND 50 (n)
Video-EEG monitoring,
PND 50-60 (n)
TNTX 39 10 16 8 5
SC 33 10 12 9 2
NC 32 10 12 9 3
Table 1. Summary of experiments 0.5 mM, MgCl27 mM, glucose 5 mM, and ascorbate 0.6 mM)
that was bubbled with 95% O2/5% CO2. Both hippocampi
were then dissected free of all adhering tissue. After remov-
ing the most septal and temporal poles, the right hippocampus
was sliced into transverse sections, approximately 3,000 μ m
in thickness. On an ice-cold plate and under direct visual con-
trol, areas CA1, CA3, and the dentate gyrus were then dis-
sected from each slice using a shard of a razor blade. All micr-
odissected samples were placed on dry ice and stored at -80℃.
The samples were homogenized by sonication in homogeniz-
ing buffer containing a protease inhibitor cocktail tablet (Co-
mplete, Mini, Roche, Germany). The homogenized samples
were placed immediately on ice, and the protein content was
assayed by the Bradford method. Each sample was separated
on 10% polyacrylamide electrophoresis gels (Novex, Invitro-
gen, Carlsbad, CA, USA) and electrotransferred to PVDF
membranes (Immobilon P, Millipore, Bedford, MA, USA).
After blocking with 5% nonfat dry milk and T-TBS
(0.05% Tween) for at least 1 hr at room temperature, and
then incubated overnight with a primary antibody, rabbit-
nNOS, 1:1,000 (Sigma-Aldrich, St. Louis, MO, USA) at 4℃.
After incubation, the PVDF membrane was washed and then
incubated with a secondary antibody (horseradish peroxidase
conjugated goat anti-rabbit IgG, 1:1,000, Sigma-Aldrich).
Immunoreactive bands were visualized by enhanced chemilu-
minescence (ECL, Amersham Pharmacia Biotech, Uppsala,
Sweden). The optical densities of the immunoreactive bands
were quantified using the Scion Image software (NIH Image)
from film exposures in the linear range for each antibody. To
ensure equal protein loading among wells, membranes were
stripped and re-probed with mouse anti-b-actin 1:1,000
(Sigma-Aldrich). Measures of optical densities for TNTX-
treated and saline-injected controls were normalized to the
optical densities of immunoreactive bands from untreated
control rats on the same gel. 
Seizure susceptibility
The volatile convulsant, flurothyl (bis-2,2,2-trifluoroethyl
ether, Sigma-Aldrich) was used to induce seizures in order to
evaluate differences in seizure susceptibility between the treat-
ment groups. Ten TNTX-treated, 10 saline-injected and 10
control rats were tested either at 20 or 50 days-of-age. Rats
were placed individually in an airtight plexiglass chamber
(11′ ′ ×6′ ′ ×6′ ′ ). Liquid flurothyl was pumped (Harvard Pu-
mp 11 Plus Advanced Single Syringe with Dual RS-232, Ha-
rvard Apparatus, Holliston, MA, USA) at a constant rate of
50 mL/min from a syringe and dripped onto filter paper on
a raised platform in the center of the chamber. The chamber
was flushed with room air and cleaned between trials at 10
min intervals. All rats were exposed to flurothyl until tonic
extension of both the forelimbs and hindlimbs were observed.
Rats were then quickly removed from the chamber and allo-
wed to recover in room air. After recovery, they were returned
to their home cage. Seizure susceptibility was expressed as the
latency between the first drop of liquid flurothyl and the first
myoclonic jerk and was measured independently by two ob-
servers.
Statistics
All data were presented as the mean±SEM. ANOVA for
comparison of two or more independent means was used in
comparing nNOS protein expression, and seizure susceptibili-
ty in tetanus toxin treated, saline injected, and control rats. 
RESULTS
Tetanus toxin-induced seizures in infancy
As has been reported previously (13), after a TNTX injec-
tion, behavioral seizures were first observed in rat pups 24-48
hr later. The frequency of seizures peaked during the monitor-
ing sessions on the second day after the injection (Fig. 1). At
that time, the rats often displayed repetitive behavioral sei-
zures which included a constellation of the following behav-
iors: wild running, clonic face and limb movements, wet dog
shakes, and head nodding. The wild running seizures were
accompanied by vocalizations, jumping, and infrequent tonic-
clonic seizures. A flurry of wet dog shakes were noted to pre-
cede or follow a wild running episode. Because wild running
episodes were the easiest to identify, wild running seizures
were counted during daily 1 hr observation periods. All TN-
TX-treated rats displayed wild running seizures and they were
never observed in saline-injected or untreated litter-mate con-
trols. Following the peak frequency on post-injection day 2,
seizures declined in number over the next 5 days (Fig. 1). Sei-
zures were not observed 7 days after the injections. On aver-
age, rats had 8.4±2.7 seizures during the daily 1 hr moni-
toring sessions. The duration of seizures varied widely but
most (66%) were less than 1 min and the remainder no more
than 2-3 min long.
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Fig. 1. Behavioral monitoring of seizures in infant rats. Average sei-
zures during the 10 hr of observation (one hour/1 day for 10 days);
8.4±2.73, Seizure frequency peaks; within 24-48 hr. 
WRS, wild running seizure; TNTX, tetanus toxin.
n=16Long-term effects of early-life seizures: Video EEG findings
Two previous studies have examined the long term effects
of TNTX-induced recurrent early-life seizures (13, 14). In the
first study, rat pups experienced severe seizure which as adults
resulted in nearly 90% of the animals displaying frequent
interictal spikes and 40% of the animals having electrograph-
ic seizures. However, in the second study, the rat pups had
milder seizures and as adults only 50% of the animals dis-
played interictal spikes and none had seizures. In the experi-
ments reported here EEG recordings were undertaken in or-
der to resolve these seemingly divergent results. The record-
ings from 3 normal control rats (Fig. 2A) and 2 saline inject-
ed rats did not display epileptiform activity. Video EEG rec-
ordings from 5 rats that had experienced recurrent seizures
early in life all displayed frequent interictal spikes (Fig. 2B, C)
in the hippocampus and/or neocortex but only 1 had elec-
trographic seizures (Fig. 2B). This rat had brief electro-
graphic events that had no behavioral accompaniments. 
Seizure susceptibility after early-life seizures
Since rats did not display spontaneous behavioral seizures,
experiments were undertaken to determine if the rats were
markedly different in their susceptibility to seizures induced
by the volatile convulsant, flurothyl. As has been reported
previously (15), following exposure to flurothyl neonatal rats
initially became quite agitated with head bobbing or turn-
ing from side to side. This was followed by attempts at run-
ning, squealing and loss of posture. The rats would then inva-
riably develop tonic posturing with both the forelimb and
hindlimbs stiffly extended. Mild cyanosis, urinary and fecal
incontinence, and salivation were frequently noted. Rats were
removed from the chamber as soon as the tonic phase began
and allowed to recover in room air. Typically the rats returned
to baseline behavior within 10-15 min. Given that rats treated
in early-life with TNTX had frequent interictal spikes. Ho-
wever, as shown in Fig. 3B while 50 day-old rats that had ex-
perienced early-life seizures were more susceptible to seizures,
this difference was quite modest. The time to seizure onset,
as measured by the first appearance of myoclonus was decr-
eased by 15% (TNTX: 138.63±11.43 sec, saline control:
162.44±21.01, control: 163.56±26.97). By comparison,
22 day-old rats, which were also treated as infants with TN-
TX, were markedly more seizure prone (Fig. 3B). Time to
seizure onset was decreased by at least 50% (TNTX: 80.38
±21.19 sec, saline control: 174.63±56.22, normal control:
157.75±14.88). Thus, the rats appeared to progress from a
period of overt spontaneous seizures (postnatal days 12-17),
through a period of marked seizure susceptibility (day 22) to
one of lessened seizure susceptibility (day 50).
Up-regulation of nNOS expression late in life
Considering a period of marked seizure susceptibility (day
22) to one of lessened seizure susceptibility (day 50) during
development in the TNTX treated rats, it seemed reasonable
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Fig. 3. Changes in seizure susceptibility between on day 22 and 50.
(A) A marked increase in seizure susceptibility is observed on day
22, when compared to litter mate controls. (B) A small (15%) but
significant decrease in the time to onset of seizures is observed
on day 50. 
NC, normal control; SC, saline control; TNTX, tetanus toxin injected.
On day 22
P<0.001 sec sec P=0.48 P<0.015 P=0.60
On day 50
A B
RH-RO
RC-RO
LH-RO
LC-RO
RH-RC
LH-LC
RH-RO
RC-RO
LH-RO
LC-RO
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RH-RO
RC-RO
LH-RO
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LH-LC
NC
TNTX1
TNTX2
Electrographic seizure
300 mV
1 sec
150 mV
1 sec
200 mV
1 sec
Fig. 2. Vedeo-EEG monitoring on day 50-60. (A)
Recordings from 3 control rats display no epilepti-
form activity. (B, C) Video EEG recordings from 5
rats that had experienced recurrent seizures in early-
life; all displayed frequent interictal spikes in the hip-
pocampus and/or neocortex but only 1 had electro-
graphic seizures (B). This rat had brief electrograph-
ic events that had no behavioral accompaniments.
Vertical arrows (   ) indicate an interictal spike. 
R, right; L, left; H, hippocampus; O, occiput; C, cor-
tex; NC, normal control; TNTX, tetanus toxin. 
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Fig. 4. Expression of nNOS level in the hippocampal subfield, CA1, CA3, and dentate gyrus of the right hippocampus on day 45 following
recurrent seizures on day 10. Distinctively, the significant up-regulation of nNOS is revealed in the CA1 and CA3 subfields of the hippocam-
pus. However, there is statistically no change in nNOS expression level in the dentate gyrus. 
NC, normal control; SC, saline control; TNTX, tetanus toxin injected; DG, dentate gyrus.
100
80
60
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20
0
P<0.01
P=0.21
TNTX SC
155 kD nNOS
b-actin 42 kD
NC TNTX SC NC TNTX SC NC
P<0.01
P=0.46
P=0.31 P=0.08
CA1 CA3 DG
to propose that during development there is a consequence
of reestablishment of neuronal and network excitability. In an
attempt to explore the reason for the decline in seizure suscep-
tibility, immunoblotting for nNOS which was known to be
related was undertaken.    
The results are shown in Fig. 4. On P50, hippocampal slices
were microdissected into CA1 and, CA3 subfields and the
dentate gyrus, and assayed separately. The results were rev-
ealed that area CA1 displayed a 300% increase in nNOS ex-
pression (TNTX: 78.7±3.77, saline control: 26.2±3.20),
and CA3 displayed an 164% increase (TNTX: 79±3.80, sal-
ine control: 48.2±3.97). However, there was statistically no
change in nNOS expression level in the dentate gyrus (TN-
TX: 57±3.01, saline control: 47±2.98). 
DISCUSSION
Several animal models have been used in the past to study
the effects of early-life seizures on brain development. Animal
models using systemic and intracerebral injections of convul-
sants such as pilocarpine and kainic acid produce prolonged
seizures in young rats (16, 17), which would be not a reason-
able model for a study of recurrent seizures in early-life. Mean-
while, the kindling model has been used successfully in rat
pups (18-21). However, even though these animals have a
lowered seizure threshold in adulthood, kindling in neonates
has not been shown to produce spontaneous seizures or an
overt epileptic condition later in life.  
Tetanus toxin-induced seizure model has been used by nu-
merous laboratories to produce seizures in adult animals of
several species (6-8). Tetanus toxin acts by enzymatically inac-
tivating the synaptic vesicle docking protein, synaptobrevin,
thus, preventing neurotransmitter release. Studies have shown
that tetanus toxin blocks the release of both excitatory and
inhibitory neurotransmitters (22). However, the toxin has also
been shown to preferentially block the release of inhibitory
neurotransmitters, primarily GABA and glycine (23). Jefferys
(24) have shown that an intrahippocampal injection in adult
rats results in epileptiform activity in both the injected and
contralateral hippocampus for up to 6-8 weeks following inje-
ction. Whether similar mechanisms underlie epileptiform
activity in adult rats that were treated as infants with tetanus
toxin is unknown. Lee et al. (9) introduced the tetanus-indu-
ced seizures models that permit study of the acute and chronic
effects of multiple early-life seizures on the developing brain.
It has been shown the clinical situation where an infant or
young child has many repeated seizures over days and weeks.
Therefore, the tetanus toxin model was certainly though to
be a valid tool to examine both the features of early-life seiz-
ures originating in the developing nervous system and the
consequences such seizures impact on brain maturation. Thus,
author selected this tetanus toxin induced seizure model to
create the ideal environment for studying the long term effects
of repetitive early-life seizures.
Preliminary observations on this study performed in vivo
suggest that tetanus toxin injection into the hippocampus of
infant rats can result in abnormal hippocampal epileptiform
activity in adulthood. Thus far, author has recorded interictal
discharges in rats at 50-60 days of age. Results from the ex-
periments reported herein demonstrate that microinjection of
tetanus toxin into infant rat brain may be used to study elec-trographic seizure activity in the developing nervous system as
well as the effects of early-life seizures on brain development. 
Although behavioral seizures can be quite stereotyped in
many rat pups, the severity of the response can vary from no
overt clinical manifestation to as many as 10 seizures per hour
during the first few days after injection. This study has shown
that routine EEG/video recordings were critical in our inter-
pretation of the behavioral responses to tetanus toxin injection.
While some of the responses attributed to the generation of
seizures, such as wild running, are clearly abnormal, other re-
sponses, such as wet dog shakes, can be observed in control
rat pups. Further, it is important to emphasize that behavioral
scoring underestimates the total number of seizures that occur
electrographically. It is not uncommon to record prolonged
focal or generalized electrographic seizures with no apparent
behavioral correlates (i.e., subclinical seizures). Thus, to obtain
an accurate record of seizure frequency, EEG/video recordings
are necessary. Although the neocortex appeared to be involved
in the generation of some electrographic seizures in rat pups,
recordings from the hippocampus indicated that this area con-
tributes significantly to seizure generation. Indeed, the behav-
ioral correlates of seizures reported herein are very similar, if
not identical, to those reported previously for amygdala kin-
dling in 2-week old rats (25). Specifically, wild running seiz-
ures, which were commonly observed in our studies, have
been reported as stage 6 seizures in kindled rat pups. Thus,
it appears that discharges in temporal lobe structures, such
as the hippocampus, contribute to behavioral seizures in the
tetanus toxin model.
The volatile convulsant, flurothyl was used to induce seiz-
ures in order to evaluate differences in seizure susceptibility
between treatment groups at 20 or 50 days-of-age. Twenty-
two day-old rats, which were also treated as infants with
TNTX, were markedly more seizure prone (Fig. 3A). The
time to seizure onset was decreased. Therefore, rats appeared
to progress from a period of overt spontaneous seizures (post-
natal days 12-17), through a period of marked seizure suscep-
tibility (day 22, Fig. 3A) to one of lessened seizure suscepti-
bility (day 50, Fig. 3B). These changes in seizure susceptibili-
ty in adult rats suggested that there may be neuronal hyper-
excitability induced by recurring seizures in infant rats and
neuronal plasticity during brain development. This study
suggested that these changes in seizure susceptibility could
be explained as the effects of seizures on the connectivity and
circuitry of the developing brain. In recent studies, there were
valid results that can support our explanation. Swann et al.
(26) reported spine loss and other persistent alterations of
hippocampal pyramidal cell dendrites at CA3 in a tetanus
toxin induced seizure model in infant rats. They introduced
alterations in the distribution of recurrent excitatory synaps-
es on dendrites could lead to promote the reverberation of
recurrent excitation in networks of mutually excitatory pyra-
midal cells.
To explain the decreased seizure susceptibility in the adult
rats which experienced recurring seizures in early-life, the
expression of nNOS level was evaluated in the hippocampal
subfield, CA1, CA3, and dentate gyrus. Distinctively, the
significant up-regulation of nNOS was revealed in the CA1
and CA3 subfields of the hippocampus. However, there was
statistically no change in nNOS expression level in the den-
tate gyrus (Fig. 4). These results resemble a previous study
of NOS mRNA expression by Elmer et al. (27). The reason
for the meaningful regional difference in nNOS expression
may be related to a seizure generation mechanism or distri-
bution of the NMDA receptor which activates NOS via glu-
tamate. Thus, repetitive seizures on developing rat brain ca-
used changes in nNOS expression level. Furthermore, there
were differences in nNOS expression especially according to
the hippocampal subfield. Which is interesting, the nNOS
is even considered to be related to neuronal development in
gestational stage (28, 29). Recently, Sunico et al. (30) suggest-
ed that NO mediates the formation of synaptic connections
and regeneration of neurons in the process of brain develop-
ment. This characteristics of nNOS expression on brain devel-
opment suggests that nNOS contributes to neuron matura-
tion as well as vulnerability in each period and region, and
NO may play an important role in the basic development of
human brain functions. 
In conclusion, repetitive seizures in early-life eventually
cause long term effects, which represents as decrease in seizure
susceptibility on the mature brain of late-life stage. Further-
more, the hippocampus of the mature brain has an increase
in nNOS expression. Considering these results, it appears that
nNOS causes a seizure prone effect on the neuronal network
and neuronal plasticity. Therefore it is suggested that nNOS
plays an important role in both down regulating the seizure
threshold and causing epileptogenesis. 
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